Discovering genetic and epigenetic vulnerabilities in urological cancers to develop targeted therapies
The Woloszynska Lab focuses on uncovering the molecular mechanisms driving urological cancers, specifically prostate and urinary bladder cancers.
By combining traditional molecular and biochemical methods with advanced tools like RNA sequencing, CRISPR-based genome engineering, and high-throughput functional screening, we aim to unravel the complexities of cancer biology.
Prostate cancer research
Focus: Health disparities of early-onset prostate cancer in African American men
Bladder cancer research
Focus: Epigenetic dysregulation in muscle-invasive bladder cancer (MIBC)
“We are not just our genes. We are the environment in which we grow up. It is very important to take into consideration all these factors when we study cancer.”
Faculty affiliations
In the news
Connect with the Woloszynska Lab
Department of Pharmacology & Therapeutics
Roswell Park Comprehensive Cancer Center
Elm and Carlton Streets
Buffalo, NY 14263